• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Ark Genomic Revolution ETF (NY: ARKG )

    26.77 UNCHANGED
    Streaming Delayed Price Updated: 8:00 PM EDT, Sep 19, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 290
    Open 26.77
    Bid (Size) 26.58 (87)
    Ask (Size) 26.85 (74)
    Prev. Close 26.77
    Today's Range 26.77 - 26.77
    52wk Range 21.97 - 34.37
    Shares Outstanding 513,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Almost Every Ark Fund Is Now Underperforming The Overall Market. Here's Why.
    The fund company focuses on the right industries, but these industries' stocks require a very particular economic backdrop and market environment. 
    Via The Motley Fool
    5 Technology ETFs At The Forefront Of The August Rebound
    Here are five technology ETFs that have been leading the way higher over the past week. 
    Via Talk Markets
    Topics ETFs

    Performance

    YTD
    -18.18%
    -18.18%
    1 Month
    +1.94%
    +1.94%
    3 Month
    +10.16%
    +10.16%
    6 Month
    -7.08%
    -7.08%
    1 Year
    -7.75%
    -7.75%

    More News

    Read More
    Cathie Wood Buys $28 Million Of Amazon, Targets Crypto; Sells $26 Million Of This Stock
    Via Investor's Business Daily
    Cathie Wood-Led Ark Invest Went Shopping For AMD, Tesla, Amazon, Coinbase, Robinhood, Meta And Palantir Shares Amid Market Crash On Monday
    Via Benzinga
    Cathie Wood's Ark Adds Over $19M Worth Of Moderna Shares After Thursday's 21% Plunge On Guidance Cut
    Via Benzinga
    Cathie Wood Touts Palantir, Coinbase And Roku As ARK's Flagship Fund Shifts Focus From Mag 6 Amid 'Whiff' Of Lower Interest Rates
    Via Benzinga
    Topics ETFs
    Why Ginkgo Bioworks Stock Is Sinking Today
    Via The Motley Fool
    Cathie Wood Goes Bargain Hunting: 2 Stocks She Just Bought
    Via The Motley Fool
    Here's How Cathie Wood (Almost) Completely Missed the Boat on Artificial Intelligence (AI) -- and the Simplest Way You Can Avoid Making the Same Mistake
    Via The Motley Fool
    Topics Artificial Intelligence ETFs
    Exposures Artificial Intelligence
    Cathie Wood Has Been Steadily Selling Shares of This Growth Stock. Should You?
    Via The Motley Fool
    Cathie Wood-LedArk Invest Cuts Robinhood Holdings Amid Bitcoin Dip, Keeps Selling Moderna Stock — Buys Palantir And AMD Shares
    Via Benzinga
    2 Cathie Wood Biotech Stocks That Could Be Worth the Risk
    Via The Motley Fool
    Cathie Wood's Ark Invest Scoops Up Shares Of AMD And Palantir — Dumps Moderna Stock Worth $4.4M
    Via Benzinga
    Investment Advisor Says 'Throwing Random Darts At Tickers' Would Beat ARKK As Cathie Wood's Flagship Fund Lags Far Behind Soaring Market: 'How Do They Do It?!'
    Via Benzinga
    Topics ETFs Stocks
    Exposures US Equities
    Cathie Wood's Ark Invest Snaps Up $3.54M Worth Of Shares In This Biopharma Company Following Positive Obesity Pipeline Update
    Via Benzinga
    Cathie Wood's Ark Empire Bleeds As Investor Outflows Spike: 'The Loyal Shareholders Have Become Frustrated'
    Via Benzinga
    Topics ETFs
    3 Cathie Wood ETFs Just Hit 4-Month Lows. Are They Worth Buying Now?
    Via The Motley Fool
    Topics ETFs
    Cathie Wood's Ark Invest Continues To Shed Coinbase, Nvidia Shares
    Via Benzinga
    Cathie Wood's Ark Buys Roku, Palantir And $1M Worth Of Stock In This Healthcare Company
    Via Benzinga
    Cathie Wood's Ark Sheds Nearly $4M Nvidia Shares And Trims Position In This AI Peer
    Via Benzinga
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Cathie Wood's Ark Invest Continues To Double Down On Moderna, Sells Nvidia Shares
    Via Benzinga
    Cathie Wood's Ark Takes Profits In Rallying Crypto Stocks, Trims Nvidia And This COVID-19 Play Further
    Via Benzinga
    Topics ETFs
    Exposures COVID-19
    Cathie Wood Is Selling This High-Yield Dividend Stock. Should You?
    Via The Motley Fool
    5 Technologies That Could Be Worth $220 Trillion By 2030, Cathie Wood's ARK Predicts: 'The Time Is Now'
    Via Benzinga
    Is Cathie Wood Buying The Rumor? Ark More Than Doubles Stake In This COVID-19 Vaccine Maker Ahead Of Flurry Of Catalysts
    Via Benzinga
    Topics ETFs
    Exposures COVID-19
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.